ALZN
Alzamend Neuro
$1.22
+$0.03 (+2.52%)Oct 29, 2026
Key metrics
The numbers that frame ALZN today
- Market cap
- $5.89M
- ROIC
- 1,534.2%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.85
- 52wk High
- $2.68
Growth
Revenue and earnings trend for ALZN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ALZN
Is Alzamend Neuro a good buy?
No. Alzamend Neuro has excellent momentum, but poor quality undercuts the setup. Growth looks poor. That could put pressure on the long-term business case.
What is the market capitalization of ALZN?
Alzamend Neuro's market capitalization is $5.89M.
What is the 52-week high for ALZN stock?
The 52-week high for Alzamend Neuro is $2.68. The current close of $1.22 is 54.5% below that high.
What is the 52-week low for ALZN stock?
The 52-week low for Alzamend Neuro is $0.85. The current close of $1.22 is 43.5% above that low.
Does ALZN stock pay dividends?
Alzamend Neuro does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ALZN?
Alzamend Neuro's Debt / Equity ratio is 0.